MariMed Inc.
MRMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $41 | $40 | $38 | $39 |
| % Growth | 2.9% | 4.4% | -2.7% | – |
| Cost of Goods Sold | $24 | $24 | $23 | $26 |
| Gross Profit | $16 | $16 | $15 | $13 |
| % Margin | 40.1% | 40.5% | 39.9% | 32.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $14 | $6 | $7 |
| SG&A Expenses | $8 | $14 | $7 | $8 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $7 | $0 | $9 | $6 |
| Operating Expenses | $15 | $15 | $16 | $14 |
| Operating Income | $2 | $1 | -$1 | -$1 |
| % Margin | 3.9% | 2.9% | -2.2% | -3.6% |
| Other Income/Exp. Net | -$2 | -$2 | -$2 | -$2 |
| Pre-Tax Income | -$0 | -$1 | -$3 | -$3 |
| Tax Expense | $3 | $1 | $3 | $5 |
| Net Income | -$3 | -$1 | -$5 | -$8 |
| % Margin | -7.2% | -3.2% | -14.4% | -21% |
| EPS | -0.01 | -0.003 | -0.014 | -0.022 |
| % Growth | -203% | 76.9% | 33.5% | – |
| EPS Diluted | -0.01 | -0.003 | -0.014 | -0.022 |
| Weighted Avg Shares Out | 393 | 390 | 383 | 379 |
| Weighted Avg Shares Out Dil | 393 | 390 | 383 | 379 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | $4 | $4 | $2 | $2 |
| % Margin | 10.9% | 10.8% | 5.1% | 4.3% |